PDCD1 and hereditary clear cell renal cell carcinoma: Renal cell carcinoma can be effectively treated with immune checkpoint inhibitors, such as the PD-1 inhibitor nivolumab, which is utilized as a second-line therapy for advanced renal cell carcinoma21.